Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

4 clinical studies listed.

Filters:

Cancer Predisposition Syndrome

Tundra lists 4 Cancer Predisposition Syndrome clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

NOT YET RECRUITING

NCT07408583

Prenatal Transplantation for Fetuses With Fanconi Anemia

The investigators aim to evaluate the safety and efficacy of in utero hematopoietic stem cell transplantation (IUHSCT) for the treatment of fetuses diagnosed with Fanconi anemia (FA) during pregnancy.

Gender: All

Updated: 2026-02-19

1 state

Fanconi Anemia
Anemia, Hypoplastic, Congenital
Congenital Bone Marrow Failure Syndromes
+5
RECRUITING

NCT06450171

Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study

The purpose of this research study is to evaluate the possible benefits and harms of screening with an investigational blood test designed to detect many types of cancer early. The name of the screening blood test being studied is: -GRAIL Galleri test

Gender: All

Ages: 22 Years - Any

Updated: 2026-01-20

1 state

Cancer Predisposition Syndrome
Predisposition, Genetic
RECRUITING

NCT05463796

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

This research study is creating a way to collect and store specimens and information from participants who may be at an increased risk of developing cancer, or has been diagnosed with an early phase of a cancer or a family member who has a family member with a precursor condition for cancer. * The objective of this study is to identify exposures as well as clinical, molecular, and pathological changes that can be used to predict early development of cancer, malignant transformation, and risks of progression to symptomatic cancer that can ultimately be fatal. * The ultimate goal is to identify novel markers of early detection and risk stratification to drive potential therapeutic approaches to intercept progression to cancer.

Gender: All

Updated: 2025-08-07

1 state

Cancer Risk
Cancer Predisposition Syndrome
Hereditary Cancer Prediction
+28
ENROLLING BY INVITATION

NCT06917794

Development of Polygenic Risk Scores in Colon Cancer Patients Through the Study of Ancestry and Diversity in Genetic Maps of the Brazilian Population - ORIGEM Project

Development of a polygenic risk score based on somatic and germline genetic information from patients with colorectal cancer

Gender: All

Ages: 18 Years - Any

Updated: 2025-04-08

7 states

Colo-rectal Cancer
Polygenic Risk Score
Somatic Mutation
+3